Stock HBIO HARVARD BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Harvard Bioscience, Inc.

Equities

HBIO

US4169061052

Delayed Nasdaq
Other stock markets
 09:47:16 2024-05-21 am EDT 		5-day change 1st Jan Change
3.33 USD +1.83% Intraday chart for Harvard Bioscience, Inc. -2.92% -37.76%
May. 07 Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Harvard Bioscience, Inc. Provides Earnings Guidance for the Full Year 2024
Harvard Bioscience Reducing Headcount
Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2024
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications At Society of Toxicology Meeting
HARVARD BIOSCIENCE INC - REMAIN ON PATH TO REDUCING NET LEVERAGE…
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Harvard Bioscience, Inc. Provides Revenue Guidance for the Year 2023
Harvard Bioscience, Inc. to Showcase Latest Innovations in Preclinical and Organoid Research At Society for Neuroscience Conference
Harvard Bioscience Unit Named as Exclusive Distributor of Etisense's Cardiorespiratory Monitoring Product
Insider Buy: Harvard Bioscience
Harvard Bioscience Seeks Acquisitions
Harvard Bioscience, Inc. Provides Earnings Guidance for Full Year 2023
Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2023
Harvard Bioscience, Inc. Announces Initial Order for Integrated Animal Behavior Monitoring System
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HBIO Stock
  4. News Harvard Bioscience, Inc.
  5. Other languages
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW